Literature DB >> 20625073

Labeling and hypertension: it is time to intervene on its negative consequences.

Gbenga Ogedegbe.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20625073      PMCID： PMC2924446          DOI： 10.1161/HYPERTENSIONAHA.110.156257

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  7 in total

1.  Psychosocial consequences of labelling in hypertension.

Authors:  J M Mossey
Journal:  Clin Invest Med       Date:  1981       Impact factor: 0.825

2.  Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test.

Authors:  M Rostrup; S E Kjeldsen; I K Eide
Journal:  Am J Hypertens       Date:  1990-12       Impact factor: 2.689

3.  Increased absenteeism from work after detection and labeling of hypertensive patients.

Authors:  R B Haynes; D L Sackett; D W Taylor; E S Gibson; A L Johnson
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

4.  Consequences of worksite hypertension screening. Changes in absenteeism.

Authors:  P Rudd; M G Price; L E Graham; B A Beilstein; S J Tarbell; P Bacchetti; S P Fortmann
Journal:  Hypertension       Date:  1987-10       Impact factor: 10.190

5.  Laboratory-based blood pressure recovery is a predictor of ambulatory blood pressure.

Authors:  Ranak Trivedi; Andrew Sherwood; Timothy J Strauman; James A Blumenthal
Journal:  Biol Psychol       Date:  2007-11-17       Impact factor: 3.251

6.  The impact of perceived hypertension status on anxiety and the white coat effect.

Authors:  Tanya M Spruill; Thomas G Pickering; Joseph E Schwartz; Elizabeth Mostofsky; Gbenga Ogedegbe; Lynn Clemow; William Gerin
Journal:  Ann Behav Med       Date:  2007-08

7.  Now we are sick: labeling and hypertension.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738
  7 in total
  5 in total

Review 1.  Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?

Authors:  Yalcin Solak; Kazuomi Kario; Adrian Covic; Nathan Bertelsen; Baris Afsar; Abdullah Ozkok; Andrzej Wiecek; Mehmet Kanbay
Journal:  Clin Exp Nephrol       Date:  2015-10-22       Impact factor: 2.801

2.  Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life.

Authors:  Tanya M Spruill; Seth D Feltheimer; Manjunath Harlapur; Joseph E Schwartz; Gbenga Ogedegbe; Youngjun Park; William Gerin
Journal:  J Psychosom Res       Date:  2013-02-15       Impact factor: 3.006

3.  The Contributions of Hypertension Diagnosis and Blood Pressure Control to Subjective Life Expectancy in a Representative Sample of Older U.S. Adults.

Authors:  Meghan Zacher; Jiwen Wang; Susan E Short
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-02-03       Impact factor: 4.077

4.  The benefits and harms of receiving a polycystic ovary syndrome diagnosis: a qualitative study of women's experiences.

Authors:  T Copp; J Hersch; D M Muscat; K J McCaffery; J Doust; A Dokras; B W Mol; J Jansen
Journal:  Hum Reprod Open       Date:  2019-10-31

5.  Psychometric properties of a condition-specific PROM for the psychosocial consequences of Labelling hypertension by using Rasch analysis.

Authors:  János Valery Gyuricza; Karl Bang Christensen; Ana Flávia Pires Lucas d'Oliveira; John Brodersen
Journal:  J Patient Rep Outcomes       Date:  2021-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.